Improved outcome in pediatric AML due to augmented supportive care

Pediatric Blood and Cancer

Volumn 59, Issue 5, 2012, Pages 919-921

  Jastaniah, Wasil ^a,b   Abrar, Mohammed Burhan ^a   Khattab, Taha M ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b UMM AL QURA UNIVERSITY   (Saudi Arabia)

Author keywords

Leukemia; Supportive care; Treatment related mortality

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUCONAZOLE; ITRACONAZOLE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLOOD; CANCER CHEMOTHERAPY; CANCER MORTALITY; CATHETER; CHILD; CLINICAL PROTOCOL; FEMALE; HEALTH CARE; HICKMAN CATHETER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN CARE; SUPPORTIVE CARE; TREATMENT OUTCOME; TREATMENT RELATED MORTALITY;

CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84866165812     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24195     Document Type: Article

References (8)

1. Woods WG. Curing childhood acute myeloid leukemia (AML) at the half-way point: Promises to keep and miles to go before we sleep. Pediatr Blood Cancer 2006; 46: 565-569.
2. Riley LC, Hann IM, Wheatley K, et al. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MRC Childhood Leukaemia Working Party. Br J Haematol 1999; 106: 436-444.
3. Creutzig U, Zimmermann M, Reinhardt D, et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004; 22: 4384-4393.
4. Lange BJ, Gerbing RB, Feusner J, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 2005; 293: 203-211.
5. Stevens RF, Hann IM, Wheatley K, et al. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: Results of the United Kingdom Medical Research Council's 10th AML trial. Br J Haematol 1998; 101: 130-140.
6. Lange BJ, Smith FO, Feusner J, et al. Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: A report from the Children's Oncology Group. Blood 2008; 111: 1044-1053.
7. Aplenc R, Alonzo TA, Gerbing RB, et al. Ethnicity and survival in childhood acute myeloid leukemia: A report from the Children's Oncology Group. Blood 2006; 108: 74-80.
8. Gupta S, Bonilla M, Fuentes SL, et al. Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador. Br J Cancer 2009; 100: 1026-1031.